Dementia Assessment Panel & Report
Overview
- Dementia is a progressive condition that affects memory, thinking, and daily functioning. An estimated 7 million Americans aged 65 and older are currently living with some form of dementia—a number expected to grow significantly in the coming decades. While cognitive symptoms typically appear later in life, the underlying changes in the brain can begin years, even decades, earlier.
- Our dementia assessment panel analyzes a wide spectrum of gene variants associated with multiple types of cognitive degeneration. This comprehensive approach enables early risk identification—empowering providers and patients to take proactive, personalized steps to support brain health well before symptoms arise.
What This Test Covers
Our Panel is structured into 6 key categories, each addressing distinct pathways that influence the risk of dementia and cognitive health
Neurodegenerative Risk Genetics
Analyzes genetic susceptibility to hallmark mechanisms of cognitive decline
- Susceptibility to Dementia
- APOE Risk Susceptibility
Microbiome–Cognitive Health Profile
Explores the genetic connection between gastrointestinal health and cognitive function
- Gut-Brain Resilience
Dementia's Metabolic Risk Indicators
Evaluates genetic interactions between metabolic function and risk of dementia
- Dementia's Disease-Metabolic Interaction Susceptibility
Homocysteine Regulation
Assesses the genetic ability to regulate homocysteine, a biomarker tied to oxidative stress and neurovascular damage
- Hyperhomocysteinemia
Neuro-Immune Health
Analyzes inflammatory response genes linked to brain degeneration
- Chronic Inflammation Susceptibility
Nutrient Metabolism Profiles
Evaluates metabolism of key neuroprotective nutrients
- Zinc Metabolism Profile
- Vitamin D Deficiency Susceptibility
Why It Matters
Early detection of genetic risk can be a game-changer allowing for preventive strategies that delay or reduce disease progression. The Dementia Assessment Panel helps address this urgency by offering
- A proactive lens into long-term cognitive risk, years before clinical signs appear.
- Precision insights across neuroinflammation, metabolism, and nutrient pathways.
- Prevention-first protocols for integrative, functional, and conventional medical approaches.
- Greater clarity for dementia clinics, neurologists, geriatric specialists, and cognitive health providers.
Who Should Take This Test
This panel is ideal for
Adults with a family history of dementia seeking proactive risk assessment.
Individuals experiencing early signs of cognitive decline or memory concerns.
Functional and integrative medicine practitioners addressing brain aging at the root.
Neurologists and dementia clinics integrating genomics into diagnostic protocols.
Providers supporting patients with brain fog, emotional changes, or mood shifts.
Anyone seeking to personalize brain health plans with precision-based insights.
What You’ll Receive
Comprehensive Genetic Report
Organized into clear categories and subcategories, covering key health areas with polygenic risk interpretations (Low, Medium, High) for each category.
Personalized Insights
Actionable insights for nutrition and supplement strategies, lifestyle modifications, and lab tests to consider for monitoring cognitive risk based on patients' unique genetic profile.
Provider Portal Access
Secure access via the ExtendingME Provider Portal for seamless report viewing, sharing.
SNP-Specific Risk Interpretations (optional, based on your requirements)
For providers seeking deeper genetic insights, we offer detailed SNP-level interpretations.
- Genetic marker identification (e.g., gene name, rsID)
- Patient genotype results and what it means for your patient's health
- Scientific explanation of how these genes influence specific health traits
Turnaround Time
Results will be available approximately 2 weeks from the receipt of the sample and will be securely delivered through the Provider Portal, enabling seamless access, viewing, and sharing of reports.
Collection Method
ExtendingME kits include all necessary self-collection devices for non-invasive, at-home saliva collection, making it easy to deliver real-time, data-driven healthcare solutions without the need for lab visits.
Take Action Before Symptoms Start
Early genetic insights. Smarter prevention. Personalized brain health powered by your DNA.
